Child safety caps fail, causing recall
The Consumer Product Safety Commission announced that Novartis Consumer Healthcare has voluntarily issued a recall of certain of its cold medications. The child-resistant caps on Triaminic and Theraflu products can fail to function properly and enable the cap to be removed by a child with the tamper-evident seal in place. This poses a risk of unintentional consumption and poisoning. These products contain acetaminophen and diphenhydramine which are required by the Poison Prevention Packaging Act to be sealed with child-resistant packaging.
This recall involves Triaminic® Syrups and Theraflu Warming Relief® Syrups for coughs, colds and fevers. There are 24 types of these two products included in the recall. A complete list of products, lot numbers and National Drug Codes (NDC) can be found at www.novartisOTC.com.
Consumers should immediately stop using the recalled product and contact Novartis for instructions on how to return the product for a full refund. Contact Novartis Consumer Healthcare toll-free at (866) 553-6742 from 8 a.m. to midnight ET, Monday through Saturday, or online at www.novartisOTC.com for more information.